SearchSearch results for: “”

Stibbe represents KLM in a summary proceedings against airline pilots. 

Sibbe advises Office Depot on the sale of its European business to The AURELIUS Group.

Stibbe advises ISDC Beheer B.V. on the sale of Integrated Development Corporation Holding (ISDC Holding) B.V., a software engineering company in which private equity firm Synergia Capital Partners holds a majority interest, to Endava.

Stibbe advises global pharmaceutical company Mylan on the merger control aspects of its USD 7.2 billion acquisition of Swedish drugmaker Meda.

Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on reaching agreement to acquire two new senior housing sites in Lochem and Rotterdam.

Stibbe advised Ahold on the employment aspects in respect of the merger between Ahold and Delhaize in a deal worth EUR 25 billion.

Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on the acquisition of a new senior housing site in Arnhem.

This is the second investment of Aedifica in The Netherlands. Aedifica has developed a portfolio of health

Stibbe has advised Sonova Holding AG on its acquisition of AudioNova B.V. from HAL Investments. The value of AudioNova is EUR 830 million.

Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on its acquisition of four senior housing sites in The Netherlands.

Stibbe represented PostNL in 25 legal proceedings initiated by self-employed workers.

On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition

Stibbe advises Apax Partners on the acquisition of RFS Holland Holding (Wehkamp and two sister companies, homeware store Fonq and appliances merchant Create2Fit).

Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion.

Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.

Stibbe advises private equity house Clayton, Dubilier & Rice (CD&R) on the acquisition of the infrastructure division of Harsco and the business combination with Brand Energy into a joint venture with Harsco.  

Stibbe advises Warner Music Group on its acquisition of Spinnin’ Records.

Stibbe advises Cimpress on the sale of Albelli to Gilde Buy Out Partners and the Albelli Management.